Dusseldorf - Delayed Quote EUR
Gubra AS (PI3.DU)
46.80
-1.42
(-2.94%)
As of 4:00:16 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
5,019
5,019
-49,419
24,340
88,513
Investing Cash Flow
87,923
87,923
-351,388
44,054
-27,179
Financing Cash Flow
-10,616
-10,616
382,789
-112,254
-12,648
End Cash Position
134,403
134,403
53,397
71,925
115,785
Capital Expenditure
-32,118
-32,118
-11,196
-14,155
-27,173
Issuance of Capital Stock
--
--
500,000
--
--
Repayment of Debt
--
--
--
-35,866
-2,056
Repurchase of Capital Stock
-606
-606
-2,802
-5,512
--
Free Cash Flow
-27,099
-27,099
-60,615
10,185
61,340
12/31/2021 - 4/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
NXOA.BE Nicox SA
0.2260
0.00%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
GON.DU Geron Corp
1.2350
+0.90%
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%
OCD1.MU ChromaDex Corp
6.20
+3.33%
GNRO.PA GeNeuro SA
0.0700
-10.26%